Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 1 August 2026.
Announcements
5,263
Total raised
£158B
disclosed amounts
The Manchester-based customer engagement platform secured the capital from investors including GP Bullhound.
"I am delighted to be able to announce the successful completion of our Series C fundraising from leading technology investors. Connex One’s growth rate has been phenomenal; it is a testament to our high-calibre global team and the value that our award-winning platform has created for our customers. I am very much looking forward to the next phase of our journey."
The Series A round was led by Beringea with backing from Amplifier, Speedinvest, and FJ Labs to support team expansion and product growth.
"Construction is one of the least digitised industries with over 95% of supply chain transactions still being conducted over the phone, email and pen and paper. Coordinating multiple suppliers and deliveries across time constrained projects is a real challenge that results in delays and costly project overruns. YardLink connects construction customers with their supply chain on a single digital platform, enabling contractors to manage their entire supply chain, streamlining procurement and ultimately helping them increase their profit margins"
The British fintech raised the capital to support new market expansion and team growth.
"Access to a business bank account should be a right, not a privilege, and we are developing serious technology to serve European and UK SMEs to make this right accessible for everyone"
The strategic financing marks the first institutional capital investment for the regulatory technology provider.
"We are highly enthusiastic to partner with CUBE for this next phase of growth. As a founder-led, category-leading Regulatory Technology (“RegTech”) business, benefiting from powerful regulatory tailwinds and market momentum, we believe CUBE is an innovation leader, and one of Europe’s most exciting high growth technology companies. We look forward to working with Ben and his ambitious team to further develop their business and drive growth."
The seed round was backed by Lionheart Ventures, Convergence Partners, and Exceptional Ventures.
"This seed funding and support from major investors who have serious experience in supporting companies to scale, our partnerships with companies in Europe and North America, and getting the green light for the first trial at our London facility, shows that Clerkenwell Health is well and truly open for business. Momentum for psychedelics-assisted therapy is building, and we’re excited to be at the forefront of that charge."
